AFC-HD AMS Life Science Second Quarter 2025 Earnings: EPS: JP¥29.93 (vs JP¥22.99 in 2Q 2024)

Simply Wall St · 04/15 22:08

AFC-HD AMS Life Science (TSE:2927) Second Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥8.43b (up 8.6% from 2Q 2024).
  • Net income: JP¥421.0m (up 30% from 2Q 2024).
  • Profit margin: 5.0% (up from 4.2% in 2Q 2024). The increase in margin was driven by higher revenue.
  • EPS: JP¥29.93 (up from JP¥22.99 in 2Q 2024).
We've discovered 3 warning signs about AFC-HD AMS Life Science. View them for free.
earnings-and-revenue-history
TSE:2927 Earnings and Revenue History April 15th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

AFC-HD AMS Life Science shares are up 3.2% from a week ago.

Risk Analysis

Be aware that AFC-HD AMS Life Science is showing 3 warning signs in our investment analysis and 1 of those is a bit concerning...